Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 726 shares of the biotechnology company’s stock after purchasing an additional 25 shares during the period. Transcend Capital Advisors LLC’s holdings in Axon Enterprise were worth $431,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Blue Trust Inc. raised its holdings in shares of Axon Enterprise by 234.5% during the 3rd quarter. Blue Trust Inc. now owns 291 shares of the biotechnology company’s stock valued at $116,000 after buying an additional 204 shares during the period. Foundations Investment Advisors LLC purchased a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $221,000. Sequoia Financial Advisors LLC raised its holdings in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after buying an additional 81 shares during the period. Signaturefd LLC raised its holdings in shares of Axon Enterprise by 16.3% during the 3rd quarter. Signaturefd LLC now owns 655 shares of the biotechnology company’s stock valued at $262,000 after buying an additional 92 shares during the period. Finally, Private Advisor Group LLC raised its holdings in shares of Axon Enterprise by 19.8% during the 3rd quarter. Private Advisor Group LLC now owns 12,382 shares of the biotechnology company’s stock valued at $4,948,000 after buying an additional 2,043 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,711 shares of company stock valued at $5,631,561. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Down 5.3 %

Axon Enterprise stock opened at $513.22 on Friday. The business has a 50 day moving average price of $619.94 and a two-hundred day moving average price of $518.66. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $39.13 billion, a price-to-earnings ratio of 132.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $265.32 and a 12 month high of $715.99.

Wall Street Analyst Weigh In

AXON has been the topic of several analyst reports. Northland Securities lifted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.